Funding Details
- Awarder
- YCombinator
- Date Award
- March 25, 2022
- Vertical
- Healthcare,Therapeutics
- Funding URL
- View Funding Page
- Valuation
-
$0
Company Info
- Founding Year
- 2022
- Company Description
- Our compounds disrupt the metabolic and
inflammatory triggers in both cancer and quasi-cancerous
cells in the tumor microenvironment. By impacting multiple cell
types, we are enabling effective, lasting cancer treatments.
- Market
- Healthcare
- Location
-
San Francisco,
CA,
USA
- Coinvestors
- YCombinator
Links